Helix BioMedix, Inc.
$1.79▲ 0.00%(+$0.00)
TickerSpark Score
73/100
▌ Solid
100
Valuation
60
Profitability
70
Growth
84
Health
50
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HXBM research report →
52-Week Range14% of range
Low
$1.00
Current
$1.79
High
$6.45
Company Overviewwww.helixbiomedix.com
About the company
Helix BioMedix, Inc. is a U. S.
- CEO
- Robin L. Carmichael
- IPO
- 1999
- Employees
- 8
- HQ
- Bothell, WA, US
Price Chart
-72.25% · this period
Valuation
- Market Cap
- $402.23K
- P/E
- -0.73
- P/S
- 0.50
- P/B
- 0.26
- EV/EBITDA
- 1.58
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 99.36%
- Op Margin
- -73.81%
- Net Margin
- -68.32%
- ROE
- -30.45%
- ROIC
- -38.72%
Growth & Income
- Revenue
- $807.19K · 0.37%
- Net Income
- $-551,512 · 43.86%
- EPS
- $-2.45 · 43.94%
- Op Income
- $-595,812
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $6.45
- 52W Low
- $1.00
- 50D MA
- $1.69
- 200D MA
- $2.29
- Beta
- 1.33
- Avg Volume
- 37
Get TickerSpark's AI analysis on HXBM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Form 4 · Filings
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 26, 03 | BEATTY R STEPHEN | buy | 60,000 |
| Dec 26, 03 | BEATTY R STEPHEN | other | 25,000 |
| Dec 26, 03 | BEATTY R STEPHEN | other | 60,000 |
| Dec 26, 03 | BEATTY R STEPHEN | other | 25,000 |
Coverage · HXBM
Our HXBM coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on HXBM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HXBM report →Internal Compare
Similar companies
Peers in the same neighborhood.